Status:
UNKNOWN
Evaluation of Colorectal Cancer Screening Strategies in China
Lead Sponsor:
Shandong University
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
50-74 years
Phase:
NA
Brief Summary
A large-scale randomized controlled trial was conducted to compare different colorectal neoplasms screening strategies in China.
Eligibility Criteria
Inclusion
- 50-74 years old
- Informed consent is available
Exclusion
- Previous colorectal cancer
- Previous colorectal resection
- Previous received cancer-related treatment (except non-melanoma skin cancer)
- Colonoscopy, sigmoidoscopy, CT colonoscopy, and barium enema were performed within 5 years
- Fecal occult blood or fecal DNA was performed within one year
- Symptoms of lower digestive tract diseases requiring colonoscopy include: (1) rectal bleeding occurred more than once in the past 6 months, (2) recorded iron deficiency anemia, and (3) recorded significant weight loss within 6 months (\> 10% of baseline weight - Suffering from other diseases that affect the benefit of screening or intolerance to colonoscopy (for example, severe pulmonary disease, end-stage renal disease, end-stage liver disease, severe heart failure or recently diagnosed cancer, except non-melanoma skin cancer)
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT05440552
Start Date
July 1 2022
End Date
December 1 2023
Last Update
July 1 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.